CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe

被引:0
|
作者
R. Paul Duffin
Michael Delbuono
Kylie Nishioka
Paul Shabram
Amish A. Patel
机构
[1] Emergent BioSolutions,
[2] Inc.,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
CVD 103-HgR live, attenuated oral cholera vaccine strain is indicated for single dose immunization against Vibrio cholerae, the causative agent for cholera. The vaccine packets containing buffer powder and lyophilized CVD 103-HgR are reconstituted in water and consumed. Studies were performed to explore the viability of CVD 103-HgR in drinking waters from common sources. CVD 103-HgR vaccine was reconstituted in bottled and tap waters from the United States and Europe, and viability was measured via colony forming units assay. Chemical analysis of select water samples was used to identify chemicals that have a negative effect on CVD 103-HgR viability. CVD 103-HgR titers were stable in all bottled waters tested, including purified bottled water, bottled spring water, and sparkling waters. However, tap water from certain cities in the US and Europe affected viability and are not compatible with vaccine. Water chemistry revealed that these tap waters contained copper, likely leached from copper plumbing. These studies give high confidence in the stability of CVD 103-HgR reconstituted in a variety of bottled waters. Waters containing copper, including tap water, should not be used to reconstitute CVD 103-HgR strain oral vaccine due to the common use of copper plumbing.
引用
收藏
相关论文
共 50 条
  • [1] CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe
    Duffin, R. Paul
    Delbuono, Michael
    Nishioka, Kylie
    Shabram, Paul
    Patel, Amish A.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] Home Administration of CVD 103-HgR: A Live Attenuated Oral Cholera Vaccine
    Duffin, Ryan Paul
    Delbuono, Michael
    Chew, Lawrence
    Johnstone, James
    Nieden, Volker
    Schwarz, Pascal
    Shabram, Paul
    Patel, Amish A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 104 (04): : 1232 - 1240
  • [3] POTENTIAL FOR REACQUISITION OF CHOLERA ENTEROTOXIN GENES BY ATTENUATED VIBRIO-CHOLERAE VACCINE STRAIN CVD 103-HGR
    KAPER, JB
    MICHALSKI, J
    KETLEY, JM
    LEVINE, MM
    [J]. INFECTION AND IMMUNITY, 1994, 62 (04) : 1480 - 1483
  • [4] Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine
    Duffin, R. Paul
    Delbuono, Michael
    Nishioka, Kylie
    Shabram, Paul
    Patel, Amish A.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 107 (02): : 388 - 392
  • [5] Update on CVD 103-HgR single-dose, live oral cholera vaccine
    McCarty, James
    Bedell, Lisa
    De Lame, Paul-Andre
    Cassie, David
    Lock, Michael
    Bennett, Sean
    Haney, Douglas
    [J]. EXPERT REVIEW OF VACCINES, 2022, 21 (01) : 9 - 23
  • [6] PaxVax CVD 103-HgR single-dose live oral cholera vaccine
    Levine, Myron M.
    Chen, Wilbur H.
    Kaper, James B.
    Lock, Michael
    Danzig, Lisa
    Gurwith, Marc
    [J]. EXPERT REVIEW OF VACCINES, 2017, 16 (03) : 197 - 213
  • [7] Successful comeback of the single-dose live oral cholera vaccine CVD 103-HgR
    Herzog, Christian
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2016, 14 (04) : 373 - 377
  • [8] Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR
    Cooper, PJ
    Chico, ME
    Losonsky, G
    Sandoval, C
    Espinel, I
    Sridhara, R
    Aguilar, M
    Guevara, A
    Guderian, RH
    Levine, MM
    Griffin, GE
    Nutman, TB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04): : 1199 - 1206
  • [9] PRELIMINARY ASSESSMENT OF THE SAFETY AND IMMUNOGENICITY OF LIVE ORAL CHOLERA VACCINE STRAIN CVD 103-HGR IN HEALTHY THAI ADULTS
    MIGASENA, S
    PITISUTTITHAM, P
    PRAYURAHONG, B
    SUNTHARASAMAI, P
    SUPANARANOND, W
    DESAKORN, V
    VONGSTHONGSRI, U
    TALL, B
    KETLEY, J
    LOSONSKY, G
    CRYZ, S
    KAPER, JB
    LEVINE, MM
    [J]. INFECTION AND IMMUNITY, 1989, 57 (11) : 3261 - 3264
  • [10] Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR
    Favre, D
    Struck, MM
    Cryz, SJ
    Viret, JF
    [J]. VACCINE, 1996, 14 (06) : 526 - 531